Welp, water is wet. It won't be up to Novo Nordisk to reduce the cost of GLP1 RAs -- it will be up to other entrants into the market (that said, there are worr

Welp, water is wet. It won't be up to Novo Nordisk to reduce the cost of GLP1 RAs -- it will be up to other entrants into the market (that said, there are worryingly few), and huge companies taking up manufacturing of GLP1s and similar compounds. At this point, companies partnering with compounding pharmacies might hit mainstream (more than it already has) and be the go-to way to get GLP1 RAs. There's already a Liraglutide (Victoza/Saxenda) generic: https://glp1.guide/content/victoza-generic-hits-the-market https://glp1.guide/content/victoza-generic-hits-the-market Though I've seen some anecdotal reports that the generic was worse than regular Victoza.